StockData
Intensity Therapeutics, Inc. logo

Intensity Therapeutics, Inc. (INTS) stock

INTSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.07−0.01 (-0.32%)

Close on Nov 16, 2026Market cap $10.02MP/E –Yield –

Intensity Therapeutics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Intensity Therapeutics

Intensity Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Intensity Therapeutics figures

See a number that looks wrong?